Skip to content
2000
Volume 17, Issue 2
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212

Abstract

Insulin resistance (IR) is a cardinal feature of type 2 diabetes mellitus (T2DM). It also is associated with multiple metabolic abnormalities which are known cardiovascular disease (CVD) risk factors. Thus, IR not only contributes to the development of hyperglycemia in T2DM patients, but also to the elevated CVD risk. Improving insulin sensitivity is anticipated to both lower the plasma glucose concentration and decrease CVD risk in T2DM patients, independent of glucose control. We review the molecular mechanisms and metabolic consequences of IR in T2DM patients and discuss the importance of addressing IR in the management of T2DM.

Loading

Article metrics loading...

/content/journals/cvp/10.2174/1570161115666171010115119
2019-03-01
2025-06-22
Loading full text...

Full text loading...

/content/journals/cvp/10.2174/1570161115666171010115119
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test